Comparative investigation of proliferation markers and their prognostic relevance in human meningiomas

Clinical Neuropathology

Volumn 20, Issue 5, 2001, Pages 190-195

  Torp, S H ^a   Lindboe, C F ^a   Granli, U S ^a   Moen, T M ^a   Nordtomme T ^a  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

Brain neoplasm; Immunohistochemistry; Ki67; Meningiomas; MIB1; Proliferation

Indexed keywords

ANTIBODY; KI 67 ANTIGEN; MONOCLONAL ANTIBODY KI 67; PARAFFIN; TUMOR MARKER;

ADULT; AGED; ANAPLASTIC CARCINOMA; ARTICLE; CANCER GRADING; CELL CYCLE S PHASE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MENINGIOMA; MITOSIS; PRIORITY JOURNAL; PROGNOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NUCLEAR; CELL DIVISION; CHILD; CHILD, PRESCHOOL; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; MALE; MENINGEAL NEOPLASMS; MENINGES; MENINGIOMA; MIDDLE AGED; MITOTIC INDEX; NUCLEAR PROTEINS; PREDICTIVE VALUE OF TESTS; S PHASE; TUMOR MARKERS, BIOLOGICAL;

EID: 0034816912     PISSN: 07225091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. MIB-1 labeling indices in benign, aggressive, and malignant meningiomas: A study of 90 tumors
2. Histopathologic features and MIB-1 labeling indices in recurrent and nonrecurrent meningiomas
3. Multiparameter flowcytometric analysis of neoplasms of the central nervous system: Correlation of nuclear antigen p 105 and DNA content with clinical behavior
4. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry
5. DNA in meningioma tissues and explant cell cultures. A glow cytometric study with clinicopathological correlates
6. The growth rate of intracranial meningiomas and its relation to histology. An analysis of 43 patients
7. Atypical and anaplastic meningiomas: Radiology, surgery, radiotherapy, and outcome
8. Prognostic significance of MIB-1, p53, and bcl-2 immunoreactivity in meningiomas
9. New Ki-67 equivalent murine monoclonal antibodies (MIB 1-3) generated against bacterially expressed parts of the Ki-67 cDNA-containing three 62 base pair repetitive elements encoding for the Ki-67 epitope
10. New antiserum against Ki-67 antigen suitable for double immunostaining of paraffin wax sections
11. Tumours of the meninges
12. Triple approach for diagnosis and grading of meningiomas: Histology, morphometry of Ki-67/Feulgen stainings, and cytogenetics
13. Meningiomas
14. Ki-67 immunoreactivity in meningiomas - Determination of the proliferative potential of meningiomas using the monoclonal antibody Ki-67
15. A typical and malignant meningiomas: A clinicopathological review
16. Classic, atypical, and anaplastic meningioma: Three histopathological subtypes of clinical relevance
17. Proliferation and DNA fragmentation in meningioma subtypes
18. No prediction of recurrence of meningiomas by PCNA and Ki-67 immunohistochemistry
19. MIB1 staining index and scoring of histologic features in meningioma. Indicators for the prediction of biologic potential and postoperative management
20. Meningioma grading. An analysis of histologic parameters
21. The prognostic significance of MIB-1, p53, and DNA flow cytometry in completely resected primary meningiomas
22. "Malignancy" in meningiomas. A clinicopathologic study of 116 patients, with grading implications
23. Which proliferation markers for routine immunohistology? A comparison of five antibodies
24. Proliferative activity in human glioblastomas: Evaluation of different Ki67 equivalent antibodies
25. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis
26. Measuring cell proliferation
27. DNA ploidy and cell-cycle analysis in intracranial meningiomas and hemangio-pericytomas: A study with high-resolution DNA flow cytometry